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Transforming growth factor (TGF)-b and BMP
signaling is mediated by Smads 1–5 (R-Smads and
Co-Smads) and inhibited by Smad7, a major hub of
regulation of TGF-b and BMP receptors by negative
feedback and antagonistic signals. The transcription
coactivator YAP and the E3 ubiquitin ligases Smurf1/
2 and Nedd4L target R-Smads for activation or
degradation, respectively. Pairs of WW domain in
these regulators bind PY motifs and adjacent CDK/
MAPK and GSK3 phosphorylation sites in R-Smads
in a selective and regulated manner. In contrast,
here we show that Smad7 binds YAP, Smurf1,
Smurf2, and Nedd4L constitutively, the binding in-
volving a PYmotif in Smad7 and no phosphorylation.
We also provide a structural basis for how regulators
that use WW domain pairs for selective interactions
with R-Smads, resort to one single versatile WW
domain for binding Smad7 to centralize regulation
in the TGF-b and BMP pathways.
INTRODUCTION
Smad transcription factors are keymediators of the transforming
growth factor beta (TGF-b) and bone morphogenetic proteins
(BMP) pathways in the control of stem cell pluripotency and
differentiation, embryo development, tissue regeneration, and
differentiated tissue homeostasis (Massague´, 1998). According
to their function, Smad proteins are classified as receptor regu-
lated Smads (R-Smads), which include Smads 1, 5, and 8 in the
BMP-driven version of the SMADpathway, and Smads 2 and 3 in
the TGF-b/Nodal/Activin pathway. R-Smads form complexes
with the common coactivator Smad (Co-Smad) Smad4. Two
inhibitory Smads (I-Smads), Smad6 and Smad7, provide critical
negative regulation to these powerful and ubiquitous pathways.
R-Smads and Smad4 consist of two Mad Homology domains
MH1 and MH2 connected by a linker region. This linker contains1726 Structure 20, 1726–1736, October 10, 2012 ª2012 Elsevier Ltda cluster of phosphorylation sites adjacent to a proline rich PY
motif. MH1 domains of R-Smads and Smad4 bind to DNA,
whereas the MH2 domain and the linker function as scaffolds
for receptors, regulator proteins, and transcription cofactors to
interact and determine the outcome of the signal (Shi and Mas-
sague´, 2003).
Several key phosphorylation steps regulate the activation
and turnover of R-Smads during the TGF-b and BMP signaling
cycles. Binding of TGF-b or BMPs to their receptors triggers
the receptor-mediated phosphorylation of R-Smads at their
C termini. This phosphorylation generates a docking site for
Smad4 for the assembly of a heterotrimeric transcriptional com-
plex. Once the complex is in the nucleus, a second round of
phosphorylations occurs in the linker region of R-Smads, creat-
ing binding sites that interact with the WW domains of activators
such as YAP and Pin1, as well as with the WW domains of the
HECT-type E3 ubiquitin ligases Nedd4L, Smurf1, and Smurf2
that prime R-Smads for degradation (Alarco´n et al., 2009; Fan
et al., 2009; Fuentealba et al., 2007; Gao et al., 2009; Kuratomi
et al., 2005). These binding interactions depend on WW domain
contacts with the PY motif and the phosphorylated sites, and
with the exception of Pin1 always involve twoWWdomains (Ara-
go´n et al., 2011).
Compared to R-Smads and Co-Smads, the I-Smads have
low sequence similarity in the MH1 domain but conserve an
MH2 domain and a linker region with a characteristic PY motif
(Figure 1A). I-Smads are expressed in response to TGF-b or
BMPs to provide negative feedback in the pathway (Bai and
Cao, 2002; Hata et al., 1998; He et al., 2002; Kavsak et al.,
2000; Nakao et al., 1997; Yan et al., 2009) and in response to
other pathways such as STAT to oppose TGF-b signaling (Ulloa
et al., 1999). Smad6 interferes with the formation of Smad1-
Smad4 complexes (Hata et al., 1998), whereas Smad7 inhibits
TGF-b and BMP receptors (Hayashi et al., 1997; Topper et al.,
1998).
Work in recent years has revealed Smad7 as a central hub
for negative regulation of activated TGF-b or BMP receptors
(Yan and Chen, 2011). Receptor-bound Smad7 recruits ubiquitin
ligases Nedd4L, Smurf1, and Smurf2 to mediate receptor poly-
ubiquitination and route the receptor to degradative endocytosis
(Ebisawa et al., 2001; Kavsak et al., 2000; Kuratomi et al., 2005).All rights reserved
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Figure 1. Domain Composition of the
Human Nedd4L, Smurf1, Smurf2, YAP, and
Smad7 Proteins and Binding Affinities,
Determined by Isothermal Titration Calo-
rimetry
(A) The three-ubiquitin ligases contain the char-
acteristic C2 domain, a central region with a vari-
able number of WW domains and the catalytic
HECT domain, each domain represented as a
rectangle. The human Yes Associated Protein
(YAP) contains a TEA binding domain, two WW
domains and a transactivator domain (TXD).
Smad7 contains a canonical MH2 group and a
divergent MH1. To highlight this divergence we
have labeled the MH1 domain using italics and in
brackets. The detailed sequence of the Smad7
linker is shown (residues 203–248). The synthe-
sized PY peptide is underlined. The WW domains
that mediate the interaction with the PY motif of
Smad7 are indicated with an arrow.
(B) ITC affinity values for the recombinant frag-
ments of Nedd4L, Smurf1, Smurf2, and YAP and
the Smad7 peptide. Binding experiments have
been performed at least three times, using two
protein expression batches, and different buffers
and temperatures. Values hereby presented were
obtained at 15C.
(C) ITC curves for the Smurf1 WW1-WW2 and the independent WW2 fragments in the presence of the Smad7 peptide. The data represented here correspond to
values acquired at 15C in Tris buffer. The affinity values were 1.7 ± 0.3 and 4.1 ± 0.6 mM with stoichiometries of 0.7 and 1, respectively.
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Smad7 Binding Mode of E3 Ubiquitin Ligases and YAPMoreover, Smad7 can simultaneously bind Smurf2 and the
protein deubiquitinase USP15, recruiting both enzymes to the
TGF-b receptor complex for an integrated control of receptor
polyubiquitination as a function of ligand concentration (Eich-
horn et al., 2012). Smad7 also binds YAP (Ferrigno et al., 2002)
providing a mechanism for sequestration of this mediator of
Hippo and BMP signaling (Alarco´n et al., 2009). These protein
interactions involve the linker region of Smad7 and the WW
domain region of Nedd4L, Smurf1/2, and YAP.
In order to advance our understanding of the functional capac-
ities of Smad7 as a hub for TGF-b or BMP pathway regulation,
we investigated the interactions between the Smad7 PY motif
region and the WW domains of its client proteins, using NMR
and ITC, ion mobility mass spectrometry, and protein interac-
tion analysis in mammalian cells. Our data reveal a surprisingly
absence of selectivity and independence from phosphorylation
in the interactions of Smad7 with these proteins, illuminating
the versatility of different WW domains as mediators of con-
vergent interactions with a common Smad7 target, in addition
to their discriminating interactions with different R-Smad
proteins.
RESULTS
Nedd4L, Smurf1, Smurf2, and YAP Use One Single WW
Domain to Bind Smad7
In order to characterize the protein regions involved in the inter-
action with the Smad7 linker we performed isothermal titration
calorimetry (ITC) binding assays using recombinant proteins,
either containing independent WW domains or all consecutive
pairs. The binding ligand was a 15 residue synthetic peptide cor-
responding to amino acid residues E203-D217 of Smad7, and
including the entire PY motif (Figure 1A).Structure 20, 1726–1In the interaction of the Smad7 peptide with Nedd4L WW
domains, ITC experiments revealed that each of the four inde-
pendent WW domains and the three possible WW-WW pairs
bind the peptide with dissociations constants in the mM range
(Figure 1B). The stoichiometry of these interactions was 1:1 in
all cases except with the WW2-WW3 pair, which bound two
equivalents of peptide per protein. To address this complication,
we used two previously characterized WW2-WW3 mutant
constructs that bind only one PY site while maintaining other
possible binding sites active (Arago´n et al., 2011). These WW2-
WW3 constructs showed peptide affinity values close to those
of the single domains. Collectively, the data show that Nedd4L
preferentially uses WW2 to interact with the Smad7 PY motif,
and that the presence of domain pairs does not increase the
affinity in vitro.
We used a similar experimental approach to investigate the
interactions of the two E3 ligases Smurf1 and Smurf2 with the
Smad7 peptide. The Smurf1 WW1 and Smurf2 WW2 domains
show very low affinity for the Smad7 peptide whereas the Smurf1
WW2 and Smurf2 WW3 showed binding dissociation constants
of 4.1 mM and a 1:1 stoichiometry with the Smad7 peptide. The
affinity of the Smurf1 WW1-WW2 and Smurf2 WW2-WW3 pairs
is 0.7 ± 0.3 mM at 5C, 1.7 ± 0.3 mM at 15C and 5.0 ± 0.3 mM
at 25C (Figures 1B and C). These values are in agreement
with previous reports for other WW interactions (Arago´n et al.,
2011; Chong et al., 2006, 2010; Gao et al., 2009; Kanelis et al.,
2006; Pires et al., 2001; Ramirez-Espain et al., 2007). However,
the affinity increase due to the presence of the WW domain
pair is about 2-fold with respect to the values obtained with
the Smurf1 WW2 or with the Smurf2 WW3 domains at a given
temperature, in contrast to previous observations that suggest
an improvement of about 10-fold (Chong et al., 2010). Further-
more, with both protein pairs the affinity is calculated with736, October 10, 2012 ª2012 Elsevier Ltd All rights reserved 1727
Figure 2. Smurf1WW1-WW2 and Smurf2WW2-WW3 Form Different Species in the Presence of Smad7 Peptide
(A) Assigned NOEs defining the hSmurf1WW1-WW1 dimer interface. Schematic representations of the possible species present in the complexes of Smurf1
WW1-WW2 pair with Smad7.
(B) Schematic representation of the Smurf1WW1 dimer. Secondary structure elements are shown in gray and in blue shades and numbered. Themodel has been
generated using the structure of the published Smurf1 WW1 domain (Arago´n et al., 2011) pdb entry 2laz and the set of assigned intermolecular NOEs.
(C) An expansion of the IM-MS data obtained for the complexes of Smurf2WW2-WW3 with the Smad7 peptide displaying nine characterized species (the full
spectrum is shown as Figure S1). Each ion was assigned to a given species based on its characteristic mobility. Abbreviations used are ML (monomer with one
ligand), D1L and D2L (dimer with one or two ligands respectively), Trim1L, Trim2L, and Trim3L (trimers with one, two, or three ligands). Numbers following the
species’ name reflect the protonation state. We have unambiguously detected dimers with one or with two bound ligands and trimers in both Smurf1 and Smurf2
complexes.
(D) Schematic representation of the species identified by IM-MS for the complexes of Smurf1 WW1-WW2 and Smurf2WW2-WW3 pairs with the Smad7 PY site.
The WW domains are represented as blue rectangles (labeled in black, white and violet to represent monomer, dimer and trimers, respectively). The Smad7
peptide is represented as a green thick-line on top of theWW2 domain. Contacts involving twoWW1 domains or between theWW1 domain of one molecule with
the linker connecting the WW pair of a second molecule are based on experimental NOEs.
(E) A region of the Ion Mobility-Mass Spectrometry data obtained for the Smurf1 WW1 dimer, (the full spectrum is shown as Figure S1). As in (C), each ion was
assigned to a given species based on its characteristic drift-time.
(F) Schematic representation of the pair ofWWdomains and the linker present in Smurf1. Themutated positions used in the ITC binding experiments and the three
strands of each WW domain are labeled. Next to it is the list of the measured affinity values.
Structure
Smad7 Binding Mode of E3 Ubiquitin Ligases and YAPa stoichiometry below 1 at all temperatures (Figure 1C) (0.6–0.8
range). ITC experiments measured in two different buffer solu-
tions (tris and ammonium acetate [pH 7]) yielded similar values
and stoichiometries.
We considered the possibility that formation of WW-WW pro-
tein aggregates could affect the interpretation of the stoichi-
ometry and affinity of Smad7 binding. Indeed, using nuclear
magnetic resonance (NMR), we observed nuclear Overhauser
effects (NOEs) in Smurf1 samples containing either the WW1
independent domain or the WW1-WW2 pair that define a dimer
via WW1-WW1 contacts (Figures 2A and 2B). Since NMR and
ITC experiments were carried out at different concentration1728 Structure 20, 1726–1736, October 10, 2012 ª2012 Elsevier Ltdranges (milimolar versus micromolar), we made use of ion
mobility-mass spectrometry (IM-MS) to investigate the potential
presence of aggregates at the protein concentrations used in
ITC experiments (30–50 mM). Using this technique we identified
the presence of monomeric complexes, protein dimers bound
to only one ligand, dimers bound to two ligands and higher
order species (Figures 2C and 2D; Figure S1 available online).
The dimers, trimers, and other higher order species were identi-
fied based on their different specific ionization masses and/or on
their characteristic drift-times. Dimers were also observed by
IM-MS analysis performed with samples containing either the
WW1or theWW2domains of Smurf1 (Figure 2E). In the presenceAll rights reserved
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Smad7 Binding Mode of E3 Ubiquitin Ligases and YAPof the Smad7 peptide the dimer population was reduced in the
sample containing the WW2 domain, while that of the WW1
domain was unaffected (Figure S1). Thus, the <1 stoichiometry
observed with the pairs under these experimental conditions
may result from the coexistence of protein monomers, dimers,
trimers, and tetramers each binding one equivalent of Smad7
peptide, plus the presence of other species bound to two, three,
or four Smad7 equivalents (Figures 2C and 2D). Since the pres-
ence of the ligand does not prevent the formation of the higher
order species, we interpret that Smurf1 WW1 and Smurf2
WW2 domains have a minor role in binding to short PY contain-
ing sequences, but an important role in protein oligomerization
and aggregation. This observation differs from a previously re-
ported interpretation of Smurf2 WW2-WW3 bound to Smad7
(Chong et al., 2010), where the WW2 domain also participates
in hydrophobic and electrostatic interactions with the Smad7
peptide. To characterize further the role of Smurf1WW1 domain,
we introduced mutations in the WW1-WW2 pair domain in
equivalent positions to those that in Smurf2 were proposed to
contact Smad7, and also two additional control mutations in
a position that did not participate in the interaction of Smurf2
and Smad7 but in the dimer formation. In all cases, single and
double mutations (Arg243Ala, Gln249Glu, Gln247, and Gln249
to Glu) reduced the affinity by 3-fold while the Arg243Glu muta-
tion reduced the affinity by 10-fold (Figure 2F). The results
suggest that these residues do not play a key role in binding
but that theymay participate in protein homodimerization. Based
on this interpretation of the binding data, we conclude that
Smurf1 and Smurf2 use their WW2 domain and WW3 domain,
respectively, as their primary binding sites for the Smad7 PY
peptide.
ITC titrations performed at 15C with the YAP WW domains
revealed that the YAP WW1 domain preferentially binds to
the Smad7 peptide, with a dissociation constant of 6.90 ±
0.28 mM, while WW2 binds with a dissociation constant 9-fold
weaker and the WW1-WW2 pair binds slightly worse than the
isolatedWW1 (9.8 ± 0.9 mMandN = 1; Figure 1B). Thus, the inter-
action with the Smad7 peptide mainly involves the YAP WW1
domain.
All together, these results suggest that in each protein a
specific, single WW domain is sufficient for high-affinity recogni-
tion of the Smad7 PY site. The WW domains that mediate the
interaction with the PY motif of Smad7 are indicated with an
arrow in the Figure 1A.
Smad7 Binds to Nedd4L WW2 Domain, Forming a Long
beta Hairpin Independent of Phosphorylation
We used NMR spectroscopy to characterize with atomic detail,
the interaction of the Nedd4LWW2 domain bound to the Smad7
linker peptide (203–217). Triple resonance NMR spectroscopy
was applied to assign theWW2 domain in this complex, whereas
filter and homonuclear spectra were used to assign the bound
Smad7 peptide and its contacts with the domain.
In the complex structure, the Nedd4LWW2domain adopts the
canonical WW fold, while the bound peptide forms an ordered
hairpin from E205 until D217, with a turn centered at positions
Y211-S212-R213. The complex is well defined, based on abun-
dant contacts detected from the Smad7 peptide with residues
located in the three strands of the domain (Figure 3A and Fig-Structure 20, 1726–1ure S2; Table 1). Y211 participates in many contacts with
Val384, His386, Arg389, and Thr391 residues in the protein,
while P207, P208, and P209 interact with the side chains of
Thr391, Trp393, and Tyr382 (we use the one letter amino acid
notation for Smad7 residues and the three letter notation for resi-
dues in the proteins). P215 is perpendicular to the beta-sheet
plane and is bound by the Tyr391, Val384, and Arg374 side
chains. We also observed interactions between E205, located
upstream of the PY motif, with the side chains of Arg380 and
of D217 with Lys378 and Arg380 (Figure 3B). The Smad7 PY
motif includes a potential phosphorylation site serine (Ser206-
Pro), equivalent to the Thr179-Pro of Smad3 whose phosphory-
lation by CDK8/9 kinases is critical for Smad3 recognition by
Pin1 and Nedd4L (Gao et al., 2009; Matsuura et al., 2010).
In contrast to the complex formed by Nedd4L and the Smad3
pT179[PY] motif (Arago´n et al., 2011), we did not detect contacts
between S206 (equivalent to T179) and the protein. Remarkably,
the interaction of E205 and also D217 with Arg380 and Lys378
resemble the electrostatic interactions used to interact with the
phosphorylated T179 in the Nedd4L WW2-Smad3 pT179[PY]
complex (Arago´n et al., 2011). To clarify the relevance that the
E205 and D217 contacts have for the complex, we designed
protein variants in which either Arg380 or Lys378, or both,
were replaced by a negatively charged residue (Glu), and quan-
tified the changes in affinity using ITC. Single changes reduce the
affinity for the Smad7 peptide 4- to 5-fold when compared to the
wild-type (Arg380Glu 15.4 ± 3.5, Lys378Glu 23.5 ± 1.5 mM,
respectively) and more than 6-fold in the double mutant
(Lys378/Arg380 to Glu, KD = 27.3 ± 2.2 mM), corroborating that
both residues in the WW2 domain participate in the interaction
with the Smad7 fragment (Figure 3C).
To further investigate the role of S206 in Smad7 binding inter-
actions, we addressed this question with the full-length proteins
in the context of HEK293T cell line. Immunoprecipitation exper-
iments were performed using plasmids encoding flag epitope-
tagged Smad7 or the Smad7 mutants S206A and AAPY. These
constructs were coexpressed with a HA epitope-tagged Nedd4L
construct in which the HECT domain catalytic Cys was mutated
to Asp in order to prevent autoubiquitination, and degradation of
the protein (Gao et al., 2009). The results of protein immunopre-
cipitation followed by western immunoblotting showed that the
Nedd4L-Smad7 interaction in mammalian cells does not require
phosphorylation of the PYmotif (Figure 3D). This result is in sharp
contrast to the important role of the corresponding phosphoryla-
tion in the interaction between Nedd4L and Smad3 (Gao et al.,
2009). The different binding modes of Nedd4L with Smad3 and
with Smad7 are schematically summarized in Figure 3E.
Structure of the Smad7 PY Motif Bound to Different
E3 Ubiquitin Ligase WW Domains
To compare the binding modes of the E3 ubiquitin ligases
Nedd4L, Smurf1, and Smurf2, we investigated the interactions
between the Smurf1 WW1-WW2 pair and the independent WW2
domain with the Smad7 peptide using triple resonance NMR
spectroscopy. Under these conditions the NMR assignment of
the complexes reveals that, both Smurf1 and Smurf2 proteins
interact with the Smad7 peptide using the WW2 domain, in
the case of Smurf1, and the WW3 for Smurf2. As observed
during the ITC titrations and IM-MS experiments, the Smurf1736, October 10, 2012 ª2012 Elsevier Ltd All rights reserved 1729
Figure 3. Structure of the Nedd4L WW2 Domain Bound to the Smad7 Linker
(A) Detailed view of the refined structure of the Nedd4LWW2 domain (364–403) in complex with the Smad7 synthesized PY fragment (203–217). The elements of
secondary structure (graphite) are numbered and key residues of the Nedd4L WW2 domain that participate in the interaction with the peptide are labeled and
highlighted in orange.
(B) Electrostatic potential surface of the Nedd4LWW2 domain with the bound Smad7 peptide (stick representation) colored in green. The lowest energy structure
displayed in (A) and (B) and the family of 25-calculated structures are shown as Figures S2A and S2B. Positively charged sites are colored in blue and negatively
charged sites in red. Key residues in Smad7 and Nedd4L are indicated (violet and black, respectively). The N- and C-terminal sites of the Smad7 peptide are
indicated with an arrow.
(C) Two residues that recognize the N-terminal part of Smad7 were both independently and jointly mutated to glutamic acid, and the effect of the change in the
interaction affinity was determined by ITC. The binding affinity decreased by approximately 7-fold with respect to the wild-type Nedd4L WW2 domain.
(D) Human HEK293T cells transduced with vectors encoding the indicated epitope-tagged proteins were subjected to immunoprecipitation (IP) with anti-Flag
antibodies and western immunoblotting with antibodies against the indicated tags (upper panels). Aliquots of cell lysates were directly subjected to immuno-
blotting as loading controls (bottom panels).
(E)Schematic representationof thedifferent bindingmodesdisplayedbyNedd4LwithSmad3andSmad7.Nedd4Lbindspreferentially to thePYsiteofSmad7using
its WW2 domain (this work) while binding to Smad3 region including the diphosphorylated site and pT[PY] motif requires theWW2-WW3 pair (Arago´n et al., 2011).
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Smad7 Binding Mode of E3 Ubiquitin Ligases and YAPWW1-WW2 pair displays a high tendency to form dimers and
other higher order aggregates.
Using 3D- and 2D-NOESY experiments we characterized a
population of dimers formed via interactions between the WW1
domains of two molecules according to intermolecular NOEs
that fit as a beta-clam. To illustrate these interactions, we gener-
ated a model using the structure of the Smurf1 WW1 domain
(pdb entry: 2laz) and the unambiguously assigned NOEs de-
tected between monomers (Figures 2A and 4A). We have also
detected a minor population of dimers formed by interactions
between the WW2 domain of one molecule and the pair of
prolines present in the linker connecting the WW1-WW2 pair of
a second molecule, that can explain the trimeric and tetrameric
species identified by IM-MS (Figures 2C and 2D). We observed
as well the dimerizing tendency with the WW2 domain of Smurf21730 Structure 20, 1726–1736, October 10, 2012 ª2012 Elsevier Ltdin the WW2-WW3 pair. The beta-clam arrangement in the dimer
is similar to that described for the WW2 domain of the mouse
Salvador homolog 1 protein (Ohnishi et al., 2007). With the WW
domain pairs we detected a broadening of the intermolecular
NOEs that defined the peptide in the bound conformation and
two sets of NOEs for the Y211 with residues in the WW2/WW3
domains. We interpreted the broadening and the presence of
the second set of signals for the Y211 aromatic ring as the result
of the peptide bound in several complexes, for instance, the
main conformations that correspond to themonomer in complex
with one ligand and the symmetric dimer with two bound ligands
in equilibriumwith an asymmetric dimer bound to a single ligand,
schematically represented in Figure 2D. At 298K and in the pres-
ence of 10% DMSO both sets of NOEs corresponding to the
Y211 collapse to one set that we interpret it as the boundAll rights reserved
Table 1. Statistics of the Five NMR Refined Complexes Analyzed with Procheck
Nedd4LWW2-S7
pdb:2lty
BMRB:18501
Smurf1 WW2-S7
pdb:2ltx
BMRB:18500
Smurf2WW3-S7
pdb:2ltz
BMRB:18502
YAPWW2-S7
pdb:2ltw
BMRB:18499
YAPWW1-S7
pdb:2ltv
BMRB:18498
Restraints used for the calculation < SA >a
Interdomain 51 85 76 74 53
Sequential (ji  jj = 1) 270 116 150 163 150
Medium range (1 < ji-jj% 4) 80 41 52 85 83
Long range (ji  jj > 4) 339 251 338 295 315
Dihedrals 70 113 91 105 101
Hydrogen bonds 10 10 10 10 10
All restraints (unambiguous) 820 616 717 732 712
Restraint ratio (47 residues) 17.4 13.1 15.2 15.5 15.2
Rmsd (A˚) from experimentalb
NOE (3103): 2.7 ± 2.8 9.1 ± 0.3 10.5 ± 1. 6 3.1 ± 0.4 7.30 ± 0.5
Bonds (3103) (A˚) 4.2 ± 1.4 7.0 ± 0.2 7.1 ± 0.3 4.1 ± 0.2 4.9 ± 0.1
Angles () 0.63 ± 0.01 0.8 ± 0.02 0.83 ± 0.06 0.5 ± 0.03 0.7 ± 0.03
Coordinate Precision (A˚)c
Backbone, all residues in
the complex (47 residues)
0.45 0.42 0.47 0.31 0.24
CNS potential energy (kcal mol-1)
Total energyd 1,698 ± 34 1483 ± 47 1238 ± 88 1,242 ± 31 1361 ± 31
Electrostatic 1,918 ± 38 1784 ± 48 1787 ± 56 1,513 ± 33 1713 ± 36
Van der Waals 165.5 ± 10.4 120.8 ± 14 57.38 ± 39.4 135.3 ± 10 113 ± 10
Bonds 14.44 ± 1.3 27.09 ± 3.5 42.91 ± 10.5 14.2 ± 1.0 19.63 ± 1.4
Angles 89.11 ± 5.4 81.63 ± 6.9 158.9 ± 23 95.18 ± 7.9 107 ± 8.4
Structural quality (% residues) 20 best structures
In most favored region
of Ramachandran plot
84.1 87.1 87.5 90.7 89.8
In additionally allowed region 13.9 12.4 12.2 9.0 11.2
a< SA > refers to the ensemble of 150 structures with the lowest energy selected from a total of 300 calculated structures.
bNo distance restraint in any of the structures included in the ensemble was violated by more than 0.3 A˚.
cRmsd between the ensemble of structures < SA > and the lowest energy structure.
dEL-J is the Lennard-Jones van der Waals energy calculated using the CHARMM-PARMALLH6 parameters. EL-J was not included in the target
function during the structure calculation.
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Smad7 Binding Mode of E3 Ubiquitin Ligases and YAPmonomer. Under these experimental conditions, we did not
observe, however, contacts between the domains in the Smurf1
WW1-WW2 pair, or between the WW1 and the Smad7 peptide
as described for the Smurf2 WW2-WW3 complex with Smad7
(Chong et al., 2010), or as we previously observed in the complex
of Smurf1 WW1-WW2 pair with Smad1 (Arago´n et al., 2011).
Based on these observations, we focused the structural
work in the WW2 domain of Smurf1 and in the WW3 of Smurf2.
As both Smurf complexes are very similar, we will describe
them in parallel, with the corresponding residues separated by
a slash. The Smurf1WW2- and Smurf2WW3-Smad7 complexes
are well defined, based on numerous contacts detected from
E205-P215 Smad7 residues with the domains (Figures 4B and
4C and Figure S3; Table 1). In both complexes the Smad7 frag-
ment also forms a turn, centered at positions Y211-S212-R213,
but it does not form a long hairpin as in the case of the Nedd4L
complex, especially in the Smurf1 complex. A comparison of
these two complexes with that of Nedd4L revealed some addi-
tional differences; for instance, E205 is interacting with Arg295/
Arg312 in the second strand, but no contacts with the peptideStructure 20, 1726–1are observed for the residues located in loop 1 of the WW
domains, which in these cases are Ser293/Thr310 and not a
Lys as in the Nedd4L WW2 domain. As a consequence, E205
and D217 are less defined in the Smurf1 WW2 and Smurf2
WW3 complexes.
Amutation introduced in the Smurf1WW2domain (Arg295Glu)
reduces the affinity to 48.6 ± 6.4 mM, suggesting an active impli-
cation of Arg295 in the peptide interaction. The equivalent muta-
tion introduced in Smurf2WW3 also reduces the affinity to 34.2 ±
1.6 mM. The complexes here described are similar to the pre-
viously characterized Smurf2WW3 and Smad7 (Chong et al.,
2006), with the main differences involving the contacts with the
N-terminal site of Smad7 (E205), the position of P215, and the
absence of intra peptide contacts from residues M216-D217.
On the other hand, they differ from the complex between the
Smurf1WW1-WW2 pair and Smad1, where both WW domains
have a direct role in ligand recognition (Figure 4D) (Alarco´n
et al., 2009; Arago´n et al., 2011) and from the complex between
Smurf2WW2-WW3 and Smad7, where the contacts with the
C-terminal part of Smad7 that we observe to occur with the736, October 10, 2012 ª2012 Elsevier Ltd All rights reserved 1731
Figure 4. Structure of the Smurf1 WW2 and Smurf2WW3 Domains Bound to the Smad7 Linker
(A) A detailed view of the binding interface of the dimer between two Smurf1 WW1 domains (residues 233–270). The orientation is rotated by 90 degrees with
respect to the schematic representation shown in Figure 2B. The unambiguously assigned NOEs that defined the dimer interface are represented with dotted
lines. Monomers are colored in orange-gray (top) and cobalt blue (bottom), with key residues highlighted.
(B) Refined structure of the Smurf1 WW2 domain (residues 277–314, light-blue) bound to the Smad7 peptide (203–217, green). Next to it is the charge distribution
on the surface of the Smurf1 WW2 domain in complex with the peptide. The structure with the lowest energy was selected for both representations. The family of
25-calculated structures is shown as Figure S3A. N and C termini of Smad7 peptide are represented with brown arrows. Key residues that participate in the
complex interaction are labeled in purple (Smad7) and in black (Smurf1). The gray line indicates the position of the R295E mutation, which decreases the binding
affinity of the complex by approximately 8-fold.
(C) Same representations as above for the Smurf2 WW3 domain (297–333, gold) bound to the Smad7 peptide (green). The R312E mutation, which decreases the
binding affinity of the complex by approximately 10-fold, is indicated with a gray line. The family of 25-calculated structures is shown as Figure S3B.
(D) Schematic representation of the different binding modes observed for Smurf1 and Smurf2 WW domains with respect to R- and I-Smad linkers. Both Smurf
proteins use a unique domain to interact with Smad7 (this work) while Smurf1 uses the WW1-WW2 pair to interact with a diphosphorylated Smad1 PY containing
site (Alarco´n et al., 2009; Arago´n et al., 2011).
Structure
Smad7 Binding Mode of E3 Ubiquitin Ligases and YAPWW3 domain were detected with the first loop of the WW2
domain (Chong et al., 2010).
Smad7 Selects YAP WW1 and Not WW2
Both YAP WW domains have been previously shown to recog-
nize PY motifs with different affinities (Arago´n et al., 2011;
Chen and Sudol, 1995; Macias et al., 1996; Pires et al., 2001).
The Smad7 fragment containing the PY motif binds to the YAP
WW1-WW2pair and to its independentWW1 domain with similar
affinities suggesting that the WW1 is the preferred binding site.
To provide a structure-based interpretation for the different affin-
ities observed between the YAP WW1 and WW2 domains, we
have determined the structure of each domain in complex with
the Smad7 fragment. As both YAP WW1 and WW2 sequences
are very similar (71% similarity), we also describe them in
parallel, with the corresponding residues separated by a slash.1732 Structure 20, 1726–1736, October 10, 2012 ª2012 Elsevier LtdIn each complex the WW1 and WW2 domains adopt the
canonical WW fold and bind to the Smad7 PY core in a similar
manner (Figures 5A and 5B and Figure S4; Table 1). The Y211
ring is accommodated in its respective tyrosine binding cavities
formed by Leu190/Ile249, His192/His251, Gln195/Lys254, and
Thr197/Thr256, while the pyrrolidine rings of Smad7 P208 and
P209 are, respectively, accommodated in the XP cavities formed
by Tyr188/Tyr247 and Trp199/Trp258. The main differences
between both complexes are the contacts observed between
Smad7 Y214 and Tyr247, Ile249, and Glu237 in the WW2 com-
plex and more significantly, the absence of interactions between
the residues located in loop 1 and the residues preceding or
following the PY site, which are observed in the complex with
WW1, and in the complexes corresponding to the three E3 ubiq-
uitin ligases. The absence of these interactions could be inter-
preted on the basis of the charge distribution of the YAP WW2All rights reserved
Figure 5. Structure of the YAP WW1 and WW2 Domains Bound to the Smad7 Linker
(A) Detailed view of the interaction of the YAPWW1 domain (residues 163–206, blue) with the Smad7 [PY] peptide (green) and next to it, the charge distribution of
the domain in the complex, shown as a semitransparent surface representation. The structure with the lowest energy was selected for both representations. The
family of 25 calculated structures is shown as Figures S4A and SB. Critical residues involved in the interaction are labeled in purple (Smad7) and in black (YAP
WW1). Both N and C termini of Smad7 peptide) are represented with arrows.
(B) A semitransparent surface representation showing the charge distribution of the YAP WW2 domain (residues 227–266, deep blue) bound to the Smad7
peptide represented as sticks (green). The family of 25 calculated structures is shown as Figure S4B. The peptide’s N terminus (Ser206) is shifted from the loop1
with respect to the orientation in the complex with WW1. The different positions of the peptide in both complexes are shown with two arrows, with a straight gray
line (WW2 complex) and with a dotted gray line (the position in the WW1 complex).
(C) Effect of point mutations in the YAP WW1 and WW2 domains. The Q186E change in the WW1 domain reduces the affinity by 2-fold, while a double
change introduced in the WW2 loop—to mimic the sequence of the first WW domain—improves the affinity by a factor of two. Mutated residues are indicated in
(A) and (B).
(D) HEK293T cells expressing the indicated constructs were analyzed as described in Figure 3D.
(E) Schematic representation of the binding modes of YAP with Smad7 (top) and with Smad1 (bottom). The interaction with the PY site of Smad7 requires only the
first WW domain, while binding to the pS and PY sites of Smad1 requires both WW domains.
Structure
Smad7 Binding Mode of E3 Ubiquitin Ligases and YAPdomain, which differs from that of the WW1 domain. The
presence of negatively charged residues in loop 1 (Asp243 and
Glu245) repels both the accommodation of the N-terminal part
of Smad7 as well as the negatively charged residues located in
the C-terminal extension of the PY motif. Point mutations intro-
duced in Asp243 and Glu245 residues to glutamine resulted in
an improved affinity by a factor of two (Figure 5C).
The YAP WW1-Smad7 structure does not support a role (or
room) for a phosphate group on S206 (S206 is tightly bound by
Trp199), suggesting that Ser206 phosphorylation would not
enhance the interaction with YAP in vivo. To explore this possi-
bility, we made use of IP experiments with either full-length pro-
tein Smad7 (wild-type) or with the S206A and AAPY variants
transfected into the HEK293T cell line and the HA-YAP con-
struct. Our experiments showed that binding is observed with
both the wild-type and the S206A variant, while the AAPY variant
cannot precipitate HA-YAP (Figure 5D) suggesting that the
Ser206 or its potential modification would play a minor role inStructure 20, 1726–1the function. In summary, the first WW domain of YAP, which
is conserved in both YAP splicing variants (Sudol, 1994), is the
preferred binding site for the Smad7 PYmotif. The discrimination
between both domains is based on the more extensive protein-
peptide contacts observed with the WW1 compared with the
WW2 domain. Again, the interaction of YAP with Smad7 is
different from that with Smad1, where both WW domains partic-
ipate in the complex and whereWW2 is responsible for the inter-
action with the Smad1 PY site while the WW1 recognizes the
phosphorylated pSerPro motif (Figure 5E).
DISCUSSION
The rules governing target recognition by HECT type E3 ubiqui-
tin ligases are open questions, and the work to date reflects
a more complex scenario than originally expected. Some family
members recognize PY motifs using a single WW domain, as is
the case of Itch binding to the Epstein Barr virus protein736, October 10, 2012 ª2012 Elsevier Ltd All rights reserved 1733
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Smad7 Binding Mode of E3 Ubiquitin Ligases and YAPLMP2A (Morales et al., 2007) and Nedd4 binding to the voltage
gated sodium channel (Kanelis et al., 2001) and to Commissure-
less (Kanelis et al., 2006). In other cases, such as the binding of
Smurf1 and Nedd4L to R-Smads, the proteins use a pair of WW
domains to expand the binding interface with a composite biding
site that includes pSer/pThr-Pro elements in addition to a canon-
ical PY motif, a combination that allows regulation of the interac-
tion by input-driven protein kinases (Alarco´n et al., 2009; Arago´n
et al., 2011; Gao et al., 2009).
The data here presented show a further versatility of WW
domains depending on the target protein in that a given HECT
E3 ubiquitin ligase can use WW domains singly (this work) or in
a combinatorial manner (Alarco´n et al., 2009; Arago´n et al.,
2011; Gao et al., 2009), depending on the target. In the case of
Nedd4L, the interaction with Smad7 involves a single WW
domain (WW2 preferentially). The high affinity of the Nedd4L
WW2 domain for the Smad7 PY region is based on aggregate
contacts with a canonical PY motif, a C-terminal extension of
this motif that aligns on the first strand of the WW2 domain,
and an electrostatic balance between a glutamic and an aspartic
acids (E205 andD217) in Smad7 and two positively charged resi-
dues located in loop 1 of the WW2 domain. In Smad2/3 a phos-
phothreonine N-terminal to the PY motif (pT179) makes a critical
contribution in the binding to a Nedd4L WW domain (Gao et al.,
2009). In the case of Smad7 a corresponding serine residue
(S206) does not need to be phosphorylated for high affinity
binding to Nedd4L; instead, an acidic residue, E205, plays the
part of pT179 in Smad3. Furthermore, Nedd4L binding to
Smad2/3 involves a second WW domain, WW3, for contacts
with a separate, diphosphorylated region downstream of the
PY motif (Arago´n et al., 2011). Thus Nedd4L binds Smad7 using
a single unregulatedWWdomain interaction even though it binds
Smad2/3 using two WW domains that require multiple phos-
phorylations of the target region by different protein kinases.
Similar principles govern the interactions of Smurf1 and
Smurf2 ubiquitin ligases with Smad7. Binding involves a unique
WW domain, whereas Smurf1 binds Smad1 using two WW
domains to recognize a PY motif and a phosphorylated motif in
the linker region. We observed neither the contacts between
the two WW domains nor the contacts between the first WW
domain and Smad7 that were described in a recent report
(Chong et al., 2010). We observed instead that the Smurf1 and
Smurf2 WW-WW pairs have a high tendency to form homo-
dimers via the WW1 domain in case of Smurf1 and via the
WW2 domain in Smurf2 (Figure 4A). The presence of Smad7
peptide did not prevent these dimerizations since the WW-WW
domain pairs bind the Smad7 peptide mainly through contacts
with the WW2 domain of Smurf1 and with the WW3 domain of
Smurf2. It has recently been reported that full-length Smurf1
forms homodimers and oligomers in vitro and in vivo through
intermolecular contacts mapped to a fragment containing the
C2 and the WW domains of one molecule and the HECT domain
of the partner (Wan et al., 2011). Furthermore, intramolecular
contacts between the C2 domain and the HECT domain of
Smurf2 have also been characterized (Wiesner et al., 2007). In
both Smurf1/2 ligases the close conformation inhibits the mech-
anism of protein self-ubiquitination (Wan et al., 2011). It is
possible that in addition to these reported interactions between
the C2 and HECT domains, the inter WW-WWcontacts detected1734 Structure 20, 1726–1736, October 10, 2012 ª2012 Elsevier Ltdin our work could also contribute to the formation of the dimers
and oligomers in vivo, and to the stabilization of the close confor-
mation of Smurf1 and 2. In the presence of two Smad7 equiva-
lents, a reverse reaction may occur with the MH1 and PY sites
of the Smad7 protein competing for the Smurf1 HECT and the
WW2 domains, respectively, pulling apart theWW1-WW1 dimer.
The result of this reaction would be the generation of two acti-
vated Smurf1-Smad7 complexes, starting from the close and
inactive full-length dimer. A similar mechanism may occur with
the Smurf1 and Smad1 interaction. These possibilities notwith-
standing, the WW-WW homodimers here detected could have
resulted from the use of recombinant protein fragments.
Our work also shows that YAP requires only the WW1 domain
for binding to the Smad7 PY region. Notably, in the interaction
with Smad1, YAP uses its WW1 domain for binding a phospho-
serine motif, and instead uses the WW2 domain for binding the
Smad1 PY motif (Arago´n et al., 2011). By solving the structures
of both YAP WW1 and WW2 complexes with Smad7 we dis-
cerned the reasons for these differences with respect to the
interaction with Smad1. The WW2 domain contains negatively
charged residues in the area where the E205 side chain is nor-
mally accommodated, destabilizing the interaction. The affinity
of the YAP WW1-WW2 pair for the composed pSP-PY site of
Smad1 is 8x higher than that of the WW1 domain for the PY
site of Smad7. However, the concentration of Smad7 in the
nucleus is high and it could compete in vivo with Smad1 for
YAP binding, providing a scenario for the inhibitory role of
Smad7.
We propose thatWW-WWpairs in these Smad regulators form
functional units that evolved to recognize PY containing regions
of variable length and complexity, including composite PY/phos-
pho-Ser/Thr motifs in R-Smads and simple PY motifs in Smad7.
These features expand the functional versatility of E3 ubiquitin
ligases by optimizing the interacting surface depending on the
needs.With Smad7, Nedd4L and Smurf1/2 act as partners in tar-
geting TGF-b receptors for ubiquitination. Smad7 may also act
as a constitutive YAP sequestration or reservoir protein. In con-
trast, R-Smads are direct targets of the ubiquitin ligases and
functional partners of YAP only in specific stages of the Smad
signaling cycle (Arago´n et al., 2011). The absence of a require-
ment for phosphorylation in the interaction with Smad7 argues
that YAP, Nedd4L and Smurf1/2 are constitutive partners of
Smad7 whereas they are conditional, phosphorylation depen-
dent regulators of R-Smads in TGF-b and BMP signal transduc-
tion. The features of Smad7 defined here provide a structural
basis for its central role as a hub for negative feedback and
crosstalk regulation in TGF-b signaling.EXPERIMENTAL PROCEDURES
Cloning
The four independent hNedd4L WW domains, the three Nedd4L WW domain
pairs were prepared as described previously (Arago´n et al., 2011; Chong et al.,
2010). Point mutations were introduced using the QuickChange site directed
mutagenesis Kit (Stratagene) with the appropriate complementary mutagenic
primers. All wild-type and variants were confirmed by DNA sequencing.
Protein Expression and Purification
Unlabeled, 15N-labeled, 13C, 15N and 2H, 13C, 15N-labeled proteins were ex-
pressed in Escherichia coli BL21 (DE3), in LB or in minimal medium (M9),All rights reserved
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Smad7 Binding Mode of E3 Ubiquitin Ligases and YAPprepared either in H2O or in D2O (99.89%, CortecNet) enriched with
15NH4Cl
and/or D-[13C] glucose as sole sources of carbon and nitrogen, respectively
(Marley et al., 2001). Proteins were purified as described (Arago´n et al.,
2011). For the NMR experiments with Smurf1/2 WW domains we have mini-
mized the aggregation tendency by concentrating the proteins (single WW2
or theWW1-WW2 pair andWW3 orWW2-WW3 for Smurf1 and 2, respectively)
in the presence of the ligand.
Transfection, Immunoprecipitation, and Immunoblotting
Transfection of the indicated plasmids was performed as described previously
(Gao et al., 2009) HEK293T cells were incubated as indicated with TGF-b1 (100
pM; R&D Systems). Immunoprecipitation and western immunoblotting were
done as described (Sapkota et al., 2007).
Smad7 Peptide Synthesis and Purification
The peptide (Ac-ELESPPPPYSRYPMD-NH2 (203–217) was synthesized using
Fmoc-solid phase peptide synthesis with a rink amide resin (Merck Chemi-
cals), in a CEM Liberty1 microwave synthesizer (0.1 mmol scale). The acety-
lated peptide was purified by RP-HPLC using a SunFire C18 Sephasil prepar-
ative column (Waters) with an A¨KTApurifier10 (GE Healthcare Life Sciences),
using a linear gradient of 10%–40% acetonitrile and 0.05% TFA and an elution
time of 20 min. The peptide was analyzed by MALDI-TOF mass spectrometry
and 2D homonuclear NMR spectroscopy.
NMR Assignment
NMR data were acquired at 285 K/298 K on a Bruker Avance III 600-MHz
spectrometer equipped with a z-pulse field gradient unit. Backbone 1H, 15N,
and 13C resonance assignments were obtained by analyzing 3D CBCA(CO)
NH and HNCBCA experiments. Side-chain resonance assignments were ob-
tained by analyzing HCCC(CO)NH, 15N-TOCSY, HCCH-TOCSY and 15N-,
13C NOESY spectra (Sattler et al., 1999). Inter- and intra molecular proton
distance restraints were obtained from peaks assigned in 2D-NOESY experi-
ments. All spectra were processed with NMRPipe/NMRDraw software (Dela-
glio et al., 1995) and were analyzed with CARA (Bartels et al., 1995). Spectra
used for the calculation were integrated using the batch integration method
of the XEASY package.
NMR Titration Experiments
15N-HSQC spectra were acquired using 300 mM 15N-labeled protein samples
to which the unlabeled peptide was added stepwise until saturation was
achieved.
Structure Determination and Refinement
Structures were calculated with CNS 1.1 (Bru¨nger et al., 1998), using only
unambiguously assigned restraints derived from NOESY experiments,
coupling constants 3J(HN, HA from HNHA spectra) and hydrogen bonds
measured from D2O exchange experiments. The protocol for the calculation
consists of two iterations of 1 and 200 structures, respectively, using
100,000 cooling steps. All calculated structures were water refined and ranked
based on minimum values of energy and violations. The water refinement
protocol is a modification of the original protocol provided with Aria (Nilges
et al., 1997), which uses all experimental restraints during the refinement
process. Analysis of the quality of the lowest energy structures was performed
using PROCHECK-NMR (Laskowski et al., 1996) and the statistics are shown
in Table 1. Images were generated with PyMOL (DeLano, 2002).
Isothermal Titration Calorimetry
ITC experiments were performed using a low volume nano ITC calorimeter
(TA instruments) and five different temperatures 5, 15, 20, 25, and 30C.
Details of the experiments are given in the Supplemental Experimental
Procedures.
Ion Mobility-Mass Spectrometry
Traveling wave ion mobility mass spectrometry experiments were performed
on a Synapt G1 HDMS mass spectrometer (Waters, Manchester, UK). Exper-
imental details are given in the Supplemental Experimental Procedures.Structure 20, 1726–1ACCESSION NUMBERS
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